FIA
CLVS

FNY Investment Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

FNY Investment Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$2K – 998
2022
Q1 		$2K Buy
+1,000
New +$1.96K ﹤0.01% 652
2021
Q1 		– Sell
-100
Closed – – 1092
2020
Q4 		$0 Hold
100
– – ﹤0.01% 967
2020
Q3 		$0 Sell
100
-1,200
-92% -$7.18K ﹤0.01% 657
2020
Q2 		$8K Buy
+1,300
New +$9.84K ﹤0.01% 296

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

FNY Investment Advisers's CLVS Position: Q2 2022 in Review

FNY Investment Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 1,000 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in CLVS in Q2 2020 and held it in 4 quarters. The position peaked at $8K in Q2 2020. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • FNY Investment Advisers reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 1,000 Clovis Oncology, Inc. shares in Q2 2022, an estimated $2K.
  • FNY Investment Advisers first reported a position in Clovis Oncology, Inc. in Q2 2020 and held it in 4 quarters.
  • FNY Investment Advisers's Clovis Oncology, Inc. position peaked at $8K in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on FNY Investment Advisers's 13F filing for Q2 2022, filed 12 Jul 2022.